Michael F. Mahoney, Chairman, President, and CEO of Boston Scientific Corp. ($BSX), sold shares on the open market seven times over the last year, totaling about $65.4 million. His most recent sale occurred on February 2, 2026. These sales rank 242nd among over 11,678 individual insiders in our database, where the average is about $8.6 million across roughly 6.4 transactions. Mahoney made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16524 | $0.00 | 16,524.0000 | 1,494,500,000 | 50.00% | 0.00% |
| Feb. 16, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7865 | $74.73 | 1,790,539.0000 | 1,494,500,000 | 0.44% | 0.00% |
| Feb. 14, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16524 | $0.00 | 1,790,129.0000 | 1,494,500,000 | 0.93% | 0.00% |
| Feb. 14, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7990 | $74.73 | 1,782,139.0000 | 1,494,500,000 | 0.45% | 0.00% |
| Feb. 16, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16265 | $0.00 | 1,798,404.0000 | 1,494,500,000 | 0.91% | 0.00% |
| Feb. 16, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16265 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 8832 | $0.00 | 26,498.0000 | 1,494,500,000 | 25.00% | 0.00% |
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Common Stock | 132190 | $0.00 | 1,764,682.0000 | 1,494,500,000 | 8.10% | 0.01% |
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Common Stock | 132190 | $0.00 | 1,896,872.0000 | 1,494,500,000 | 7.49% | 0.01% |
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 8832 | $0.00 | 1,905,704.0000 | 1,494,500,000 | 0.47% | 0.00% |
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 132099 | $74.73 | 1,773,605.0000 | 1,494,500,000 | 6.93% | 0.01% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 13704 | $0.00 | 1,639,118.0000 | 1,494,500,000 | 0.84% | 0.00% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 6626 | $74.12 | 1,632,492.0000 | 1,494,500,000 | 0.40% | 0.00% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 13704 | $0.00 | 27,408.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Restricted Stock Units | 55652 | $0.00 | 55,652.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Stock Option (Right to Buy) | 131329 | $0.00 | 131,329.0000 | 1,494,500,000 | 9999.99% | 0.01% |
| Feb. 2, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 1200 | $94.06 | 1,785,115.0000 | 1,494,500,000 | 0.07% | 0.00% |
| Feb. 2, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 49407 | $24.55 | 1,739,968.0000 | 1,494,500,000 | 2.92% | 0.00% |
| Feb. 2, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 49407 | $0.00 | 98,814.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Feb. 2, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 46347 | $0.00 | 231,739.0000 | 1,494,500,000 | 16.67% | 0.00% |
| Feb. 2, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 159701 | $93.49 | 1,625,414.0000 | 1,494,500,000 | 8.95% | 0.01% |
| Feb. 2, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 46347 | $27.09 | 1,786,315.0000 | 1,494,500,000 | 2.66% | 0.00% |
| Nov. 20, 2025 | CVS HEALTH Corp | $CVS | Mahoney Michael F | Director | A | Deferred Stock Units | 2022 | $76.04 | 4,613.3964 | 1,269,000,000 | 78.02% | 0.00% |
| Oct. 29, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 88197 | $0.00 | 1,766,557.0000 | 1,495,500,000 | 5.25% | 0.01% |
| Oct. 29, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 73996 | $0.00 | 1,840,553.0000 | 1,495,500,000 | 4.19% | 0.00% |
| Oct. 30, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 149992 | $0.00 | 1,690,561.0000 | 1,495,500,000 | 8.15% | 0.01% |
| June 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56212 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| June 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 74522 | $104.05 | 1,768,281.0000 | 1,485,900,000 | 4.04% | 0.01% |
| June 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 49407 | $24.55 | 1,842,803.0000 | 1,485,900,000 | 2.75% | 0.00% |
| June 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56212 | $17.26 | 1,793,396.0000 | 1,485,900,000 | 3.24% | 0.00% |
| June 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 49407 | $0.00 | 148,221.0000 | 1,485,900,000 | 25.00% | 0.00% |
| June 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 89921 | $103.39 | 1,678,360.0000 | 1,485,900,000 | 5.09% | 0.01% |
| May 15, 2025 | CVS HEALTH Corp | $CVS | Mahoney Michael F | Director | A | Common Stock | 144 | $60.47 | 6,345.0000 | 1,262,000,000 | 2.32% | 0.00% |
| May 15, 2025 | CVS HEALTH Corp | $CVS | Mahoney Michael F | Director | A | Deferred Stock Units | 2543 | $60.47 | 2,542.5831 | 1,262,000,000 | 9999.99% | 0.00% |
| May 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 49407 | $24.55 | 1,901,627.0000 | 1,485,900,000 | 2.67% | 0.00% |
| May 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56212 | $17.26 | 1,852,220.0000 | 1,485,900,000 | 3.13% | 0.00% |
| May 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 73161 | $102.92 | 1,828,466.0000 | 1,485,900,000 | 3.85% | 0.00% |
| May 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 91282 | $102.13 | 1,737,184.0000 | 1,485,900,000 | 4.99% | 0.01% |
| May 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56212 | $0.00 | 56,212.0000 | 1,485,900,000 | 50.00% | 0.00% |
| May 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 49407 | $0.00 | 197,628.0000 | 1,485,900,000 | 20.00% | 0.00% |
| April 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 49407 | $0.00 | 247,035.0000 | 1,485,900,000 | 16.67% | 0.00% |
| April 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56211 | $0.00 | 112,424.0000 | 1,485,900,000 | 33.33% | 0.00% |
| April 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 164442 | $100.01 | 1,796,008.0000 | 1,485,900,000 | 8.39% | 0.01% |
| April 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 49407 | $24.55 | 1,960,450.0000 | 1,485,900,000 | 2.59% | 0.00% |
| April 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56211 | $17.26 | 1,911,043.0000 | 1,485,900,000 | 3.03% | 0.00% |
| Feb. 18, 2025 | CVS HEALTH Corp | $CVS | Mahoney Michael F | Director | P | Common Stock (By Trust) | 30000 | $66.70 | 39,566.0000 | 1,262,000,000 | 313.61% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 18334 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16524 | $0.00 | 1,844,953.0000 | 1,485,900,000 | 0.90% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7990 | $106.11 | 1,836,963.0000 | 1,485,900,000 | 0.43% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16265 | $0.00 | 1,853,228.0000 | 1,485,900,000 | 0.89% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7865 | $106.11 | 1,845,363.0000 | 1,485,900,000 | 0.42% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 18334 | $0.00 | 1,863,697.0000 | 1,485,900,000 | 0.99% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 8865 | $106.11 | 1,854,832.0000 | 1,485,900,000 | 0.48% | 0.00% |
| Feb. 13, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Restricted Stock Units | 35330 | $0.00 | 35,330.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Stock Option (Right to Buy) | 90915 | $0.00 | 90,915.0000 | 1,485,900,000 | 9999.99% | 0.01% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16524 | $0.00 | 33,048.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16265 | $0.00 | 16,265.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 13704 | $0.00 | 41,112.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 13704 | $0.00 | 1,835,055.0000 | 1,485,900,000 | 0.75% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 6626 | $105.77 | 1,828,429.0000 | 1,485,900,000 | 0.36% | 0.00% |
| Feb. 11, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 62915 | $105.98 | 1,821,351.0000 | 1,485,900,000 | 3.34% | 0.00% |
| Feb. 11, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Common Stock | 130118 | $0.00 | 1,884,266.0000 | 1,485,900,000 | 7.42% | 0.01% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Performance Share Units | 57121 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 25656 | $89.32 | 1,754,148.0000 | 1,485,900,000 | 1.44% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 57121 | $0.00 | 1,779,804.0000 | 1,485,900,000 | 3.32% | 0.00% |
| Nov. 26, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 7800 | $0.00 | 1,722,683.0000 | 1,487,400,000 | 0.45% | 0.00% |
| Nov. 21, 2024 | CVS HEALTH Corp | $CVS | Mahoney Michael F | Director | A | Common Stock | 2200 | $57.10 | 6,201.0000 | 1,262,000,000 | 54.99% | 0.00% |
| Nov. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 55676 | $0.00 | 0.0000 | 1,487,400,000 | 100.00% | 0.00% |
| Nov. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56211 | $17.26 | 1,837,585.0000 | 1,487,400,000 | 3.16% | 0.00% |
| Nov. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 55676 | $16.31 | 1,893,261.0000 | 1,487,400,000 | 3.03% | 0.00% |
| Nov. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 2596 | $85.17 | 1,890,665.0000 | 1,487,400,000 | 0.14% | 0.00% |
| Nov. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 160182 | $84.74 | 1,730,483.0000 | 1,487,400,000 | 8.47% | 0.01% |
| Nov. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56211 | $0.00 | 168,635.0000 | 1,487,400,000 | 25.00% | 0.00% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 82085 | $84.94 | 1,781,374.0000 | 1,487,400,000 | 4.40% | 0.01% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56211 | $0.00 | 224,846.0000 | 1,487,400,000 | 20.00% | 0.00% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 55675 | $0.00 | 55,676.0000 | 1,487,400,000 | 50.00% | 0.00% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56211 | $17.26 | 1,888,476.0000 | 1,487,400,000 | 3.07% | 0.00% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 55675 | $16.31 | 1,944,151.0000 | 1,487,400,000 | 2.95% | 0.00% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 80692 | $84.31 | 1,863,459.0000 | 1,487,400,000 | 4.15% | 0.01% |
| Sept. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | S | Common Stock | 162777 | $81.17 | 1,832,265.0000 | 1,463,500,000 | 8.16% | 0.01% |
| Sept. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 55675 | $0.00 | 111,351.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Sept. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Stock Option (Right to Buy) | 56211 | $0.00 | 281,057.0000 | 1,463,500,000 | 16.67% | 0.00% |
| Sept. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 56211 | $17.26 | 1,939,367.0000 | 1,463,500,000 | 2.98% | 0.00% |
| Sept. 5, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 55675 | $16.31 | 1,995,042.0000 | 1,463,500,000 | 2.87% | 0.00% |
| Aug. 30, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 114237 | $0.00 | 1,964,360.0000 | 1,463,500,000 | 6.17% | 0.01% |
| Aug. 30, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 176245 | $0.00 | 1,883,156.0000 | 1,463,500,000 | 8.56% | 0.01% |
| Aug. 30, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | G | Common Stock | 95041 | $0.00 | 2,059,401.0000 | 1,463,500,000 | 4.84% | 0.01% |
| May 16, 2024 | CVS HEALTH Corp | $CVS | Mahoney Michael F | Director | A | Common Stock | 2184 | $57.52 | 4,001.0000 | 1,290,000,000 | 120.20% | 0.00% |
| May 2, 2024 | CVS HEALTH Corp | $CVS | Mahoney Michael F | Director | P | Common Stock (By Trust) | 9181 | $54.49 | 9,566.0000 | 1,290,000,000 | 2384.68% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7214 | $65.82 | 1,830,847.0000 | 1,463,500,000 | 0.39% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Deferred Stock Units | 16307 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 18333 | $0.00 | 18,334.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16265 | $0.00 | 32,530.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7233 | $65.82 | 1,850,123.0000 | 1,463,500,000 | 0.39% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16307 | $0.00 | 1,857,356.0000 | 1,463,500,000 | 0.89% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 8131 | $65.82 | 1,841,049.0000 | 1,463,500,000 | 0.44% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 18333 | $0.00 | 1,849,180.0000 | 1,463,500,000 | 1.00% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16265 | $0.00 | 1,838,061.0000 | 1,463,500,000 | 0.89% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 7328 | $65.95 | 1,821,796.0000 | 1,463,500,000 | 0.40% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 16523 | $0.00 | 1,829,124.0000 | 1,463,500,000 | 0.91% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Restricted Stock Units | 16523 | $0.00 | 49,572.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Stock Option (Right to Buy) | 144516 | $0.00 | 144,516.0000 | 1,463,500,000 | 9999.99% | 0.01% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Restricted Stock Units | 54816 | $0.00 | 54,816.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | A | Common Stock | 146666 | $0.00 | 1,877,648.0000 | 1,463,500,000 | 8.47% | 0.01% |
| Feb. 6, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 65047 | $0.00 | 1,812,601.0000 | 1,463,500,000 | 3.46% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Performance Share Units | 95919 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.01% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | M | Common Stock | 95919 | $0.00 | 1,771,086.0000 | 1,463,500,000 | 5.73% | 0.01% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Mahoney Michael F | Chairman, President & CEO | F | Common Stock | 40104 | $57.81 | 1,730,982.0000 | 1,463,500,000 | 2.26% | 0.00% |
| May 2, 2023 | BAXTER INTERNATIONAL INC | $BAX | Mahoney Michael F | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 30,089.0000 | 683,000,000 | 17.92% | 0.00% |